Markets.com Logo

BRTX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.47$
  • Previous Close
    1.5054$
  • 52 Week Change
    1.34$
  • Day Range
    -0.04$
  • 52 Week High/Low
    1.21$ - 2.55$
  • Dividend Per Share
    --
  • Market cap
    12 045 K$
  • EPS
    -0.3
  • Beta
    76.345
  • Volume
    --

About

BioRestorative Therapies, Inc. (BRTX.US) is a clinical-stage company focused on stem cell therapies, primarily targeting chronic health conditions. Their lead program, BRTX-100, is an autologous (using the patient's own cells) stem cell therapy targeting chronic lumbar disc disease (CLDD). The company is also exploring the potential of its platform technology for other indications. BioRestorative Therapies is headquartered in Melville, New York.
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--
Technology stock to watch in 2026: What is the new NVDA stock price target?

Technology stock to watch in 2026: What is the new NVDA stock price target?

Frances Wang|--
BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

Frances Wang|--
Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Frances Wang|--

Factors

Clinical Trial Results: Positive clinical trial data typically drives the price upward, while negative results usually cause it to fall.

Regulatory Approvals: FDA approvals or rejections significantly impact investor sentiment and stock price.

Market Sentiment: General investor optimism or pessimism regarding biotechnology stocks can affect BRTX.US.

Financial Performance: Company's revenue, profitability, and cash flow influence its perceived value.

Competitor Activities: Advances or setbacks by competitors in the regenerative medicine field can impact BRTX.US.

Partnerships/Collaborations: Strategic alliances and collaborations often boost investor confidence.

Management Changes: Changes in key leadership positions can lead to uncertainty and price volatility.

Economic Conditions: Broader economic trends and market conditions can impact investor risk appetite and BRTX.US valuation.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--
Financial market for beginners: How financial markets work, how to invest?

Financial market for beginners: How financial markets work, how to invest?

Ghko B|--